Skip to main content
. 2019 Mar 5;93(6):e01865-18. doi: 10.1128/JVI.01865-18

FIG 4.

FIG 4

Pathogenicity in vivo of FILORAB3. (A) Survival in newborn BALB/c mice (n = 8) intracranially challenged with escalating doses of live FILORAB3 compared to live parental rabies virus (BNSP). (B) Survival in adult SCID mice (n = 8) challenged intramuscularly with 6 log10 FFU of either FILORAB3, BNSP as a positive control, or PBS as a negative control. The log-rank (Mantel-Cox) test was used for comparison of survival curves to assess significant differences in survival.